Managing Editor
@ShahidNShah
@ShahidNShah
Evaluation of the Effectiveness and Cost-Effectiveness of the Chronic Disease Co-Care (CDCC) Pilot Scheme
The Chronic Disease Co-Care (CDCC) Pilot Scheme is a government-subsidized program that aims to provide targeted copayment for the screening and management of hypertension, diabetes mellitus and pre-diabetes in the private healthcare sector. Studies have found that concurrent screening and management with a multi-disciplinary intervention is cost-saving because of the reduction in the rates of premature mortality, complications and utilization of public health services. This study aims to evaluate the quality of care, acceptability, effectiveness and cost-effectiveness of the CDCC Pilot Scheme.
Medigy Insights
The Chronic Disease Co‑Care (CDCC) Pilot Scheme — which provides subsidised screening and management for hypertension, diabetes and pre-diabetes through private primary-care providers — offers a promising model for early detection and management of chronic diseases before complications arise.
Continue reading at link.springer.com
Make faster decisions with community advice
- 10 Healthcare Technology Trends for 2025
- 2025: Innovations in Health Care Software Development
- 6 Major Healthcare Technology Trends: 2026 Outlook
- Advancing Remote and Continuous Cardiovascular Patient Monitoring through a Novel and Resource-efficient IoT-Driven Framework
- COBRA: Multimodal Sensing Deep Learning Framework for Remote Chronic Obesity Management via Wrist-Worn Activity Monitoring
Next Article
-
Collaborative Management for Chronic Diseases and Depression: A Double Heterogeneity-based Multi-Task Learning Method
Wearable sensor technologies and deep learning are transforming healthcare management. Yet, most health sensing studies focus narrowly on physical chronic diseases. This overlooks the critical need …
